Cargando…

HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress

The HECT E3 ubiquitin ligase HACE1 is a tumour suppressor known to regulate Rac1 activity under stress conditions. HACE1 is increased in the serum of patients with heart failure. Here we show that HACE1 protects the heart under pressure stress by controlling protein degradation. Hace1 deficiency in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liyong, Chen, Xin, Sharma, Parveen, Moon, Mark, Sheftel, Alex D., Dawood, Fayez, Nghiem, Mai P., Wu, Jun, Li, Ren-Ke, Gramolini, Anthony O., Sorensen, Poul H., Penninger, Josef M., Brumell, John H., Liu, Peter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959209/
https://www.ncbi.nlm.nih.gov/pubmed/24614889
http://dx.doi.org/10.1038/ncomms4430
Descripción
Sumario:The HECT E3 ubiquitin ligase HACE1 is a tumour suppressor known to regulate Rac1 activity under stress conditions. HACE1 is increased in the serum of patients with heart failure. Here we show that HACE1 protects the heart under pressure stress by controlling protein degradation. Hace1 deficiency in mice results in accelerated heart failure and increased mortality under haemodynamic stress. Hearts from Hace1(−/−) mice display abnormal cardiac hypertrophy, left ventricular dysfunction, accumulation of LC3, p62 and ubiquitinated proteins enriched for cytoskeletal species, indicating impaired autophagy. Our data suggest that HACE1 mediates p62-dependent selective autophagic turnover of ubiquitinated proteins by its ankyrin repeat domain through protein–protein interaction, which is independent of its E3 ligase activity. This would classify HACE1 as a dual-function E3 ligase. Our finding that HACE1 has a protective function in the heart in response to haemodynamic stress suggests that HACE1 may be a potential diagnostic and therapeutic target for heart disease.